AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.

[1]  T. Honjo,et al.  Opinion: uracil DNA glycosylase (UNG) plays distinct and non-canonical roles in somatic hypermutation and class switch recombination. , 2014, International immunology.

[2]  Alberto Martin,et al.  Genomic Uracil Homeostasis during Normal B Cell Maturation and Loss of This Balance during B Cell Cancer Development , 2014, Molecular and Cellular Biology.

[3]  T. Grundström,et al.  Expression and recruitment of uracil-DNA glycosylase are regulated by E2A during antibody diversification. , 2014, Molecular immunology.

[4]  N. Liabakk,et al.  Activation-induced cytidine deaminase (AID) is localized to subnuclear domains enriched in splicing factors. , 2014, Experimental cell research.

[5]  H. Krokan,et al.  A robust, sensitive assay for genomic uracil determination by LC/MS/MS reveals lower levels than previously reported. , 2013, DNA repair.

[6]  David T. W. Jones,et al.  Signatures of mutational processes in human cancer , 2013, Nature.

[7]  M. Bjørås,et al.  Base excision repair. , 2013, Cold Spring Harbor perspectives in biology.

[8]  Jason B. Nikas,et al.  APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.

[9]  J. D. Di Noia,et al.  A combined nuclear and nucleolar localization motif in activation-induced cytidine deaminase (AID) controls immunoglobulin class switching. , 2013, Journal of molecular biology.

[10]  Finn Drabløs,et al.  Transcription profiling during the cell cycle shows that a subset of Polycomb-targeted genes is upregulated during DNA replication , 2013, Nucleic acids research.

[11]  David Dunson,et al.  Genetic heterogeneity of diffuse large B-cell lymphoma , 2013, Proceedings of the National Academy of Sciences.

[12]  B. Domon,et al.  Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer* , 2012, Molecular & Cellular Proteomics.

[13]  Derek J. Bailey,et al.  Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics* , 2012, Molecular & Cellular Proteomics.

[14]  Alexandre Orthwein,et al.  Activation induced deaminase: how much and where? , 2012, Seminars in immunology.

[15]  Adrian L. Smith,et al.  Ectopic restriction of DNA repair reveals that UNG2 excises AID-induced uracils predominantly or exclusively during G1 phase , 2012, The Journal of experimental medicine.

[16]  Ty C. Voss,et al.  DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes , 2012, Nature.

[17]  Michel C. Nussenzweig,et al.  Translocation-Capture Sequencing Reveals the Extent and Nature of Chromosomal Rearrangements in B Lymphocytes , 2011, Cell.

[18]  B. Roche,et al.  Deoxyuridine Triphosphate Incorporation during Somatic Hypermutation of Mouse VkOx Genes after Immunization with Phenyloxazolone , 2010, The Journal of Immunology.

[19]  Nina M. Donghia,et al.  Widespread genomic breaks from activation-induced cytidine deaminase are prevented by homologous recombination , 2016 .

[20]  Agustín Correa,et al.  High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease. , 2010, Blood.

[21]  N. Probst-Hensch,et al.  AID protein expression in chronic lymphocytic leukemia/small lymphocytic lymphoma is associated with poor prognosis and complex genetic alterations , 2010, Modern Pathology.

[22]  R. Sposto,et al.  Activation-Induced Cytidine Deaminase Accelerates Clonal Evolution in BCR-ABL1 – Driven B-Cell Lineage Acute Lymphoblastic Leukemia , 2010 .

[23]  N. Maizels,et al.  Temporal Regulation of Ig Gene Diversification Revealed by Single-Cell Imaging1 , 2009, The Journal of Immunology.

[24]  M. Lieber,et al.  The B cell mutator AID promotes B lymphoid blast crisis and drug resistance in chronic myeloid leukemia. , 2009, Cancer cell.

[25]  N. Liabakk,et al.  Extracts of proliferating and non-proliferating human cells display different base excision pathways and repair fidelity. , 2009, DNA repair.

[26]  W. Klapper,et al.  The expression of activation induced cytidine deaminase in follicular lymphoma is independent of prognosis and stage , 2009, Histopathology.

[27]  H. Krokan,et al.  The rate of base excision repair of uracil is controlled by the initiating glycosylase. , 2008, DNA repair.

[28]  S. Conticello.  The AID/APOBEC family of nucleic acid mutators , 2008, Genome Biology.

[29]  D. Schatz,et al.  Two levels of protection for the B cell genome during somatic hypermutation , 2008, Nature.

[30]  T. Grundström,et al.  B-cell receptor activation inhibits AID expression through calmodulin inhibition of E-proteins , 2008, Proceedings of the National Academy of Sciences.

[31]  O. Jensen,et al.  Cell cycle-specific UNG2 phosphorylations regulate protein turnover, activity and association with RPA , 2007, The EMBO journal.

[32]  E. Selsing,et al.  Activation-Induced Cytidine Deaminase-Dependent DNA Breaks in Class Switch Recombination Occur during G1 Phase of the Cell Cycle and Depend upon Mismatch Repair1 , 2007, The Journal of Immunology.

[33]  M. Nussenzweig,et al.  A role for AID in chromosome translocations between c-myc and the IgH variable region , 2007, The Journal of experimental medicine.

[34]  S. Akira,et al.  Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors. , 2007, Immunity.

[35]  H. Krokan,et al.  Uracil–DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanisms , 2007, Nucleic acids research.

[36]  C. Kunz,et al.  Cell cycle regulation as a mechanism for functional separation of the apparently redundant uracil DNA glycosylases TDG and UNG2 , 2007, Nucleic acids research.

[37]  F. Papavasiliou,et al.  Regulation of AID expression in the immune response , 2007, The Journal of experimental medicine.

[38]  R. Brezinschek,et al.  MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation. , 2007, Blood.

[39]  M. Otterlei,et al.  Uracil in DNA--general mutagen, but normal intermediate in acquired immunity. , 2007, DNA repair.

[40]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[41]  N. Kakazu,et al.  Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice , 2007, Proceedings of the National Academy of Sciences.

[42]  H. Nilsen,et al.  Monoclonal B-cell hyperplasia and leukocyte imbalance precede development of B-cell malignancies in uracil-DNA glycosylase deficient mice. , 2005, DNA repair.

[43]  D. Barnes,et al.  C → T mutagenesis and γ‐radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases , 2005, The EMBO journal.

[44]  L. Reiniger,et al.  Aberrant somatic hypermutation and expression of activation‐induced cytidine deaminase mRNA in mediastinal large B‐cell lymphoma , 2005, British journal of haematology.

[45]  Ryan T. Phan,et al.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells , 2004, Nature.

[46]  L. Pasqualucci,et al.  Expression of the AID protein in normal and neoplastic B cells. , 2004, Blood.

[47]  Ash A. Alizadeh,et al.  AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity , 2004, Leukemia.

[48]  B. Epe,et al.  Incorporation of dUMP into DNA is a major source of spontaneous DNA damage, while excision of uracil is not required for cytotoxicity of fluoropyrimidines in mouse embryonic fibroblasts. , 2004, Carcinogenesis.

[49]  H. Ohno,et al.  Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL , 2004, Leukemia.

[50]  A. Fischer,et al.  Human uracil–DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination , 2003, Nature Immunology.

[51]  D. Barnes,et al.  Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas , 2003, Oncogene.

[52]  R. Bende,et al.  Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. , 2003, Cancer research.

[53]  Kevin R Coombes,et al.  High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. , 2003, Blood.

[54]  W. Klapper,et al.  Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. , 2003, Blood.

[55]  Reuben S Harris,et al.  RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. , 2002, Molecular cell.

[56]  F. Skorpen,et al.  hUNG2 Is the Major Repair Enzyme for Removal of Uracil from U:A Matches, U:G Mismatches, and U in Single-stranded DNA, with hSMUG1 as a Broad Specificity Backup* , 2002, The Journal of Biological Chemistry.

[57]  D. Barnes,et al.  Immunoglobulin Isotype Switching Is Inhibited and Somatic Hypermutation Perturbed in UNG-Deficient Mice , 2002, Current Biology.

[58]  M. Neuberger,et al.  Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase , 2002, Nature.

[59]  M. Neuberger,et al.  AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification , 2002, Nature.

[60]  Riccardo Dalla-Favera,et al.  Mechanisms of chromosomal translocations in B cell lymphomas , 2001, Oncogene.

[61]  D. Barnes,et al.  Excision of deaminated cytosine from the vertebrate genome: role of the SMUG1 uracil–DNA glycosylase , 2001, The EMBO journal.

[62]  H. Nilsen,et al.  Analysis of uracil-DNA glycosylases from the murine Ung gene reveals differential expression in tissues and in embryonic development and a subcellular sorting pattern that differs from the human homologues. , 2000, Nucleic acids research.

[63]  T. Honjo,et al.  Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells* , 1999, The Journal of Biological Chemistry.

[64]  F. Skorpen,et al.  Nuclear and mitochondrial uracil-DNA glycosylases are generated by alternative splicing and transcription from different positions in the UNG gene. , 1997, Nucleic acids research.

[65]  J. Keasling,et al.  Targeted proteomics for metabolic pathway optimization. , 2012, Methods in molecular biology.

[66]  M. Nussenzweig,et al.  Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes , 2011, Nature Immunology.

[67]  D. Schatz,et al.  Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions , 2011, Nature Immunology.

[68]  L. Pasqualucci,et al.  AID is required for germinal center–derived lymphomagenesis , 2008, Nature Genetics.

[69]  J. Błasiak,et al.  [Base excision repair]. , 2005, Postepy biochemii.

[70]  A. Durandy,et al.  Repair of U/G and U/A in DNA by UNG2-associated repair complexes takes place predominantly by short-patch repair both in proliferating and growth-arrested cells. , 2004, Nucleic acids research.

[71]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .